Inhibition of Akirin2 was associated with the loss of tumorigenic potential as evidenced by increased anchorage-dependent growth, reduced metastasis and tumor size (Komiya et al. 2008; 2014). The gene discussed is AKIRIN2; the disease is neoplasm.